Does rebamipide prevent gastric mucosal injury in patients taking aspirin and clopidogrel?
First Department of Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan, mitsu@hama-med.ac.jp.
Mitsushige
M
Sugimoto
Takahiro
T
Uotani
Takahisa
T
Furuta
D000409:Alanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001241:Aspirin / Q000009:adverse effects*; D000077144:Clopidogrel; D006471:Gastrointestinal Hemorrhage / Q000517:prevention & control*; D006801:Humans; D008297:Male; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects*; D015363:Quinolones / Q000627:therapeutic use*; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives*
D000897:Anti-Ulcer Agents; D010975:Platelet Aggregation Inhibitors; D015363:Quinolones; D000077144:Clopidogrel; C052785:rebamipide; D000409:Alanine; D013988:Ticlopidine; D001241:Aspirin